These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 20519252

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prevalence of human papillomavirus antibodies in males and females in England.
    Desai S, Chapman R, Jit M, Nichols T, Borrow R, Wilding M, Linford C, Lowndes CM, Nardone A, Pebody R, Soldan K.
    Sex Transm Dis; 2011 Jul; 38(7):622-9. PubMed ID: 21317688
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Seroprevalence of human papillomavirus types 16 and 18 in the general population in Taiwan: implication for optimal age of human papillomavirus vaccination.
    Chen CJ, Viscidi RP, Chuang CH, Huang YC, Chiu CH, Lin TY.
    J Clin Virol; 2007 Feb; 38(2):126-30. PubMed ID: 17210269
    [Abstract] [Full Text] [Related]

  • 5. Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia.
    Newall AT, Brotherton JM, Quinn HE, McIntyre PB, Backhouse J, Gilbert L, Esser MT, Erick J, Bryan J, Formica N, MacIntyre CR.
    Clin Infect Dis; 2008 Jun 01; 46(11):1647-55. PubMed ID: 18444790
    [Abstract] [Full Text] [Related]

  • 6. HPV 6/11, 16, 18 seroprevalence in men in two US cities.
    Dunne EF, Nielson CM, Hagensee ME, Papenfuss MR, Harris RB, Herrel N, Gourlie J, Abrahamsen M, Markowitz LE, Giuliano AR.
    Sex Transm Dis; 2009 Nov 01; 36(11):671-4. PubMed ID: 19809385
    [Abstract] [Full Text] [Related]

  • 7. Seroprevalence and risk factors for human papillomavirus in Taiwan.
    Wang IJ, Viscidi R, Hwang KC, Lin TY, Chen CJ, Huang LM, Chen HH, Chen CJ.
    J Trop Pediatr; 2008 Feb 01; 54(1):14-8. PubMed ID: 17984124
    [Abstract] [Full Text] [Related]

  • 8. Seroprevalence of antibodies against human papillomavirus (HPV) types 16 and 18 in four continents: the International Agency for Research on Cancer HPV Prevalence Surveys.
    Vaccarella S, Franceschi S, Clifford GM, Touzé A, Hsu CC, de Sanjosé S, Pham TH, Nguyen TH, Matos E, Shin HR, Sukvirach S, Thomas JO, Boursaghin L, Gaitan J, Snijders PJ, Meijer CJ, Muñoz N, Herrero R, Coursaget P, IARC HPV Prevalence Surveys Study Group.
    Cancer Epidemiol Biomarkers Prev; 2010 Sep 01; 19(9):2379-88. PubMed ID: 20826835
    [Abstract] [Full Text] [Related]

  • 9. Seroprevalence of seven high-risk HPV types in The Netherlands.
    Scherpenisse M, Mollers M, Schepp RM, Boot HJ, de Melker HE, Meijer CJ, Berbers GA, van der Klis FR.
    Vaccine; 2012 Oct 19; 30(47):6686-93. PubMed ID: 22959981
    [Abstract] [Full Text] [Related]

  • 10. Frequency of antibodies against E4 and E7 from human papillomavirus type 16 in Mexican soldiers.
    Plett-Torres T, Cruz-Valdez A, Esquivel-Guadarrama F, Hernández-Nevarez P, Lazcano-Ponce E, Gutiérrez-Xicotencatl L.
    Arch Virol; 2007 Jan 19; 152(1):97-114. PubMed ID: 16896549
    [Abstract] [Full Text] [Related]

  • 11. Seroprevalence of human papillomavirus types 6, 11, 16 and 18 in Chinese women.
    Ji J, Sun HK, Smith JS, Wang H, Esser MT, Hu S, Pretorius RG, Chen W, Belinson JL, Qiao YL.
    BMC Infect Dis; 2012 Jun 20; 12():137. PubMed ID: 22715915
    [Abstract] [Full Text] [Related]

  • 12. Epidemiologic factors associated with seropositivity to human papillomavirus type 16 and 18 virus-like particles and risk of subsequent infection in men.
    Lu B, Hagensee ME, Lee JH, Wu Y, Stockwell HG, Nielson CM, Abrahamsen M, Papenfuss M, Harris RB, Giuliano AR.
    Cancer Epidemiol Biomarkers Prev; 2010 Feb 20; 19(2):511-6. PubMed ID: 20086109
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prevalence of human papillomavirus antibodies in young female subjects in England.
    Jit M, Vyse A, Borrow R, Pebody R, Soldan K, Miller E.
    Br J Cancer; 2007 Oct 08; 97(7):989-91. PubMed ID: 17726462
    [Abstract] [Full Text] [Related]

  • 16. Model-based estimation of viral transmissibility and infection-induced resistance from the age-dependent prevalence of infection for 14 high-risk types of human papillomavirus.
    Bogaards JA, Xiridou M, Coupé VM, Meijer CJ, Wallinga J, Berkhof J.
    Am J Epidemiol; 2010 Apr 01; 171(7):817-25. PubMed ID: 20231211
    [Abstract] [Full Text] [Related]

  • 17. A Serological Epidemiological Survey of Antibodies against 4 HPV Subtypes in Uygur Women in Xinjiang.
    Husaiyin S, Han L, Mamat H, Husaiyin K, Wang L, Niyazi M.
    Jpn J Infect Dis; 2016 Jul 22; 69(4):273-8. PubMed ID: 26255734
    [Abstract] [Full Text] [Related]

  • 18. Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected and uninfected women from Brazil.
    Nicol AF, Grinsztejn B, Friedman RK, Veloso VG, Cunha CB, Georg I, Pilotto JH, Moreira RI, Castro CA, Silver B, Viscidi RP.
    J Clin Virol; 2013 Jun 22; 57(2):147-51. PubMed ID: 23490398
    [Abstract] [Full Text] [Related]

  • 19. Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004.
    Markowitz LE, Sternberg M, Dunne EF, McQuillan G, Unger ER.
    J Infect Dis; 2009 Oct 01; 200(7):1059-67. PubMed ID: 19719390
    [Abstract] [Full Text] [Related]

  • 20. A Bivariate Mixture Model for Natural Antibody Levels to Human Papillomavirus Types 16 and 18: Baseline Estimates for Monitoring the Herd Effects of Immunization.
    Vink MA, Berkhof J, van de Kassteele J, van Boven M, Bogaards JA.
    PLoS One; 2016 Oct 01; 11(8):e0161109. PubMed ID: 27537200
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.